(Q43737293)

English

KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts

scientific article published on 26 April 2014

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

object named as

Markus Mezger

2

0 references

Martin Bornhäuser

3

object named as

Martin Bornhäuser

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

author name string

Sebastian U Michaelis

1

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Rudolf Trenschel

4

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Gernot Stuhler

5

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Birgit Federmann

6

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Lena Oevermann

7

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Lothar Kanz

8

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Rupert Handgretinger

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Wolfgang A Bethge

10

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

publication date

26 April 2014

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Annals of Hematology

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

93

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

1579-1586

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Innate or adaptive immunity? The example of natural killer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Novel transplant strategies for generating graft-versus-leukemia effect in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Targeting natural killer cells and natural killer T cells in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

HLA and KIR polymorphisms affect NK-cell anti-tumor activity.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Human diversity in killer cell inhibitory receptor genes

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Donors with group B KIR haplotypes improve relapse-free survival after unrelated hematopoietic cell transplantation for acute myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Genotypes of NK cell KIR receptors, their ligands, and Fcγ receptors in the response of neuroblastoma patients to Hu14.18-IL2 immunotherapy.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

A novel real-time PCR method for KIR genotyping.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Donor natural killer cell allorecognition of missing self in haploidentical hematopoietic transplantation for acute myeloid leukemia: challenging its predictive value.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Molecules and mechanisms of the graft-versus-leukaemia effect

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

The beneficial role of inhibitory KIR genes of HLA class I NK epitopes in haploidentically mismatched stem cell allografts may be masked by residual donor-alloreactive T cells causing GVHD.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Temporal, quantitative, and functional characteristics of single-KIR-positive alloreactive natural killer cell recovery account for impaired graft-versus-leukemia activity after haploidentical hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Improved survival with inhibitory killer immunoglobulin receptor (KIR) gene mismatches and KIR haplotype B donors after nonmyeloablative, HLA-haploidentical bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Donor activating KIR3DS1 is associated with decreased acute GVHD in unrelated allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Donor-recipient combinations of group A and B KIR haplotypes and HLA class I ligand affect the outcome of HLA-matched, sibling donor hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Killer Ig-like receptor (KIR) compatibility plays a role in the prevalence of acute GVHD in unrelated hematopoietic cell transplants for AML.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Use of NK cell activity in cure by transplant

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

HLA-C-dependent prevention of leukemia relapse by donor activating KIR2DS1.

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Activating natural cytotoxicity receptors of natural killer cells in cancer and infection

1 reference

https://api.crossref.org/works/10.1007%2FS00277-014-2084-2

21 January 2018

Identifiers

10.1007/S00277-014-2084-2

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43737293&oldid=2102935054"